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Background. In adults, attention-deﬁcit/hyperactivity disorder (ADHD) and bipolar disorder (BD) have certain overlap-
ping symptoms, which can lead to uncertainty regarding the boundaries of the two disorders. Despite evidence of cog-
nitive impairments in both disorders separately, such as in attentional and inhibitory processes, data on direct
comparisons across ADHD and BD on cognitive–neurophysiological measures are as yet limited.
Method. We directly compared cognitive performance and event-related potential measures from a cued continuous
performance test in 20 women with ADHD, 20 women with BD (currently euthymic) and 20 control women.
Results. The NoGo-N2 was attenuated in women with BD, reﬂecting reduced conﬂict monitoring, compared with
women with ADHD and controls (both p < 0.05). Both ADHD and BD groups showed a reduced NoGo-P3, reﬂecting
inhibitory control, compared with controls (both p < 0.05). In addition, the contingent negative variation was signiﬁcantly
reduced in the ADHD group (p = 0.05), with a trend in the BD group (p = 0.07), compared with controls.
Conclusions. These ﬁndings indicate potential disorder-speciﬁc (conﬂict monitoring) and overlapping (inhibitory con-
trol, and potentially response preparation) neurophysiological impairments in women with ADHD and women with BD.
The identiﬁed neurophysiological parameters further our understanding of neurophysiological impairments in women
with ADHD and BD, and are candidate biomarkers that may aid in the identiﬁcation of the diagnostic boundaries of the
two disorders.
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Introduction
Attention-deﬁcit/hyperactivity disorder (ADHD) and
bipolar disorder (BD) are common psychiatric condi-
tions in adults, affecting around 2–4% and 1–2% of
the adult population, respectively (Merikangas et al.
2011; Willcutt, 2012). Although ADHD and BD re-
present distinct conditions, their diagnostic formula-
tions present certain areas of symptomatic overlap. In
adults, ADHD may be manifest with some symptoms
common to mania/hypomania, such as distractibility,
psychomotor restlessness and talkativeness (Skirrow
et al. 2012; Asherson et al. 2014). Additionally, both dis-
orders are associated with features of mood dysregula-
tion, such as irritability and emotional lability (Skirrow
et al. 2012, 2014; GL Kitsune et al. unpublished observa-
tions). Of note, ADHD symptoms are chronic and trait-
like, while BD symptoms of mania and depression
tend to occur for a distinct period of time (Asherson
et al. 2014). Yet, individuals with BD may still show
residual symptoms of distractibility and mood dysre-
gulation (overlapping with ADHD), and residual cog-
nitive and functional impairments between episodes
(Torres et al. 2007; Henry et al. 2013). Importantly,
symptomatic similarities can result in uncertainty
regarding the boundaries of the two disorders, and
difﬁculties in distinguishing between the two disorders
in some patients, which in turn may result in inappro-
priate treatment decisions (Asherson et al. 2014).
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Adults with ADHD or BD may display similar cog-
nitive impairments. For example, both ADHD and
euthymic BD are associated with poor accuracy in at-
tentional and inhibitory processing tasks (Robinson
et al. 2006; McLoughlin et al. 2010; Torralva et al.
2011) and increased reaction time variability (RTV),
which may reﬂect short-term ﬂuctuations in attentional
performance (Brotman et al. 2009; Kuntsi et al. 2010;
Kuntsi & Klein, 2012). Comparative studies across
ADHD and BD, using identical measures, may aid in
the identiﬁcation of attentional and inhibitory deﬁcits
underlying overlapping symptoms and functional im-
pairment, yet empirical data are currently limited.
The investigation of neurophysiological processes
with event-related potentials (ERPs) provides a direct
measure of covert brain activity underlying behaviour-
al performance with millisecond temporal resolution,
and may enable a sensitive comparison of cognitive
proﬁles in ADHD and BD (Banaschewski & Brandeis,
2007; McLoughlin et al. 2014a). Several previous stud-
ies on attentional and inhibitory processing in ADHD
have explored ERPs during the cued continuous per-
formance test (CPT-OX), which involves presentation
of cue, target (Go) and non-target (NoGo) stimuli
and requires a response only when a target follows a
cue (van Leeuwen et al. 1998; Banaschewski et al.
2004). A reduced fronto-central P3 has consistently
been reported in response to NoGo stimuli
(NoGo-P3) in children, adolescents and adults with
ADHD compared with controls, reﬂecting abnormal
inhibitory control (Valko et al. 2009; Doehnert et al.
2010; McLoughlin et al. 2010, 2011; Albrecht et al.
2013; Tye et al. 2014). Attenuations in a parietal P3
after presentation of cue stimuli (Cue-P3) and in the
subsequent contingent negative variation (CNV), a
late negative potential before the occurrence of the
next stimulus, have also been found in individuals
with ADHD, reﬂecting impaired attentional orienting
and response preparation, respectively (Doehnert
et al. 2010; McLoughlin et al. 2010, 2011; Albrecht
et al. 2013), although case–control differences in these
components have not been reported in all studies
(Dhar et al. 2010; Skirrow, 2012). Differences between
adults with ADHD and control adults are generally
not found in other ERP components elicited by this
task; such as the P3 in response to target (Go-P3),
reﬂecting response execution, and the N2 to non-target
stimuli (NoGo-N2), indexing conﬂict monitoring,
which refers to the ability to monitor ongoing behav-
iour, detect conﬂict and adjust response selection
(Yeung & Cohen, 2006; McLoughlin et al. 2010). N2
deﬂections are particularly elicited by high-conﬂict
trials, such as non-target or incongruent stimuli, and
are attenuated in ADHD individuals in paradigms in-
ducing higher conﬂict-monitoring demands than the
CPT-OX, such as ﬂanker tasks, suggesting possible
modulations of this component by task and stimuli
(Barry et al. 2009; McLoughlin et al. 2009, 2014b).
In ERP studies, BD has been associated with attenua-
tions in early sensory and attentional ERP components
(e.g. mismatch negativity, P50 and P2) in auditory
tasks (Hall et al. 2007; Jahshan et al. 2012; Cabranes
et al. 2013; Swann et al. 2013). Reduced P3 enhance-
ments to target stimuli have been reported in adults
with BD in studies using a visual paradigm with stand-
ard, deviant and target conditions (Maekawa et al.
2013) and using an oddball paradigm (Hall et al.
2007), but not in all studies (Schulze et al. 2008;
Bestelmeyer, 2012). Some evidence also indicates
impairments in conﬂict monitoring in adults with
BD, indexed by reduced N2 in response to target stim-
uli with an auditory oddball task (Ethridge et al. 2012)
and reduced error-related negativity (ERN) in error
responses (Morsel et al. 2014). Despite initial evidence
that may suggest impairments in ERPs of attentional
and inhibitory processing in BD, however, ERP data
on these processes are limited, and no studies, to our
knowledge, have used the CPT-OX.
Direct comparisons on cognitive performance and
ERP measures in ADHD and BD are sparse. One
study on adults with ADHD and adults with BD inves-
tigating ERP measures of reward processing found
signiﬁcant differences in the amplitude of a reward-
sensitive P3, which was attenuated in ADHD but
enhanced in BD participants compared with controls
(Ibanez et al. 2012). However, no study to date has
compared ERP components associated with attentional
and inhibitory processing in both disorders using the
CPT-OX. In addition, most studies of this kind, espe-
cially on ADHD, have used male samples because,
among children, ADHD is more prevalent in males
than in females, and very little is known about these
processes in females. Yet, a similar prevalence of
ADHD has been reported in both adult men and
women (Faraone & Biederman, 2005; Das et al. 2012).
Similarly, comparable gender ratios have been found
for BD in adults (Pini et al. 2005).
The aim of the current study was to directly compare
cognitive performance and ERP measures associated
with attentional and inhibitory processing in ADHD
and BD in adults. This study was conducted on an all-
female sample, in order to match the groups on gender
but also to explore the neglected area of ERP indices
associated with these processes in females. Based on
previous studies of male participants (McLoughlin
et al. 2010; Albrecht et al. 2013; Doehnert et al. 2013),
we predicted that women with ADHD would show
reduced NoGo-P3, Cue-P3 and CNV, but normal
NoGo-N2. Given the limited and mixed results in
ERP studies of BD individuals and the lack of similar
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studies using the CPT-OX, we adopted an exploratory
approach for the BD group and for the comparison
with ADHD.
Method
Sample
The sample for this study consisted of 60 adult women
aged between 20 and 52 years, divided into three
groups: 20 with ADHD, 20 with BD and 20 controls.
Participants with ADHD were recruited from the
National Adult ADHD Clinic at the Maudsley
Hospital, where any female cases meeting inclusion
criteria were considered for potential inclusion in the
study. Participants with BD were recruited from the
Maudsley Psychosis Clinic and a sample that had pre-
viously participated in another research study (Hosang
et al. 2012). Control participants were recruited from
the Mindsearch volunteer database maintained by
the Institute of Psychiatry, King’s College London,
which comprises several thousand potential partici-
pants. Participants were randomly selected from all
those meeting recruitment criteria for this study.
Diagnosis in the clinical groups was conﬁrmed by
checkingmedical records fordetailsofdiagnosis andpsy-
chiatric history, following Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV)
criteria (APA, 2000). All of the ADHD participants
had a current combined-type diagnosis or a current
inattentive-type diagnosis with sufﬁcient symptoms of
hyperactivity–impulsivity in childhood to meet a child-
hood combined-type diagnosis. Participants in the BD
group had a diagnosis of BD type I, having experienced
at least onemanic episode in thepast. Thosewhowere ex-
periencing a manic episode at the time of the assessment
were excluded; all participants included in the BD group
were currently euthymic. Exclusion criteria for all groups
were drug or alcohol dependency in the last 6 months,
autism, epilepsy, neurological disorders, brain injury,
past electroconvulsive therapy, current involvement in
another research trial likely to alter symptom severity,
pregnancy or a limited proﬁciency in the English lan-
guage. Individuals with ADHD and individuals with
BD with a reported co-morbidity of both ADHD and
BD were also excluded. Control participants, who
reported a history of psychiatric disorders or who were
taking psychiatric medication, were excluded from the
study. Co-morbidity in the clinical groups and lack of
psychiatric disorders in the control group were further
assessed through clinical evaluations when participants
underwent the cognitive–electroencephalographic (EEG)
assessment for this study. Further details on the clinical
assessment of this sample can be found elsewhere (GL
Kitsune et al. unpublished observations). In brief,
ADHD was excluded in the BD group after conducting
the Diagnostic Interview for ADHD in Adults (DIVA
v. 2.0; Kooij & Francken, 2007). BD was excluded in
the ADHD group by checking for a history of past epi-
sodes of depression or hypomania/mania and evaluat-
ing current mood symptoms using the Altman
Self-Rating Mania Scale (Altman et al. 1997) and the
BeckDepression Inventory (Beck et al. 1996), and current
and lifetime ever symptoms using the Young Mania
Rating Scale (Young et al. 1978). The ADHD and BD
groups did not differ signiﬁcantly on any of the mood
scales for current symptoms (GL Kitsune et al. unpub-
lished observations).
All participants had normal or corrected-to-normal
vision. Mean age did not differ by group (F2,59 = 1.63,
p = 0.21), with a mean age of 37.40 (S.D. = 7.70) for the
ADHD group, 40.30 (S.D. = 7.70) for the BD group and
36.7 (S.D. = 4.30) for the control group. Participants’ in-
telligence quotients (IQs) were assessed with the
Wechsler Abbreviated Scale of Intelligence, fourth edi-
tion (Wechsler, 1999) and did not differ between
groups (F2,58 = 1.37, p = 0.26), with mean IQs of 104
(S.D. = 17.90) for ADHD, 108 (S.D. = 12.50) for BD and
112 (S.D. = 14.20) for control participants. Participants
with ADHD were asked to stop taking any stimulant
medication prescribed for their ADHD 48 h prior to
the assessment. For ethical reasons, participants were
not asked to stop taking mood stabilizers (70% of the
BD group), anti-psychotic medication (40% of the BD
group) or anti-depressants (7% of the ADHD group
and 25% of the BD group) they had been prescribed.
All participants were asked to refrain from caffeinated
drinks and nicotine 2 h prior to the testing session.
Ethical approval for the study was granted by the
Camberwell St Giles Research Ethics Committee (ap-
proval number 11/LO/0438) and all participants pro-
vided informed consent.
Procedure and cognitive performance measures
Participants attended a single 4.5 h research session (in-
cluding breaks) for cognitive–EEGassessment, IQassess-
ment and clinical interviews. The task was a CPT-OX,
ﬂanker version (Doehnert et al. 2008; McLoughlin et al.
2010, 2011). This is a cued-Go/NoGo task that probes at-
tention, preparation and response inhibition or control.
The task consists of 400 letter arrays formedof a centre let-
ter with incompatible ﬂankers on each side to increase
difﬁculty for adults. Each letter array was presented for
150 ms with a stimulus onset asynchrony (SOA) of 1.65
s in a pseudo-randomized order at the centre of a com-
puter monitor. The tasks involved the presentation of
80 cues (XOX) followed either by 40 Go (OXO) and 40
NoGo (XDX) stimuli, alternated with random letter
sequences as distractors. Participants were instructed to
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respond only to Cue-Go sequences by pressing a but-
ton as quickly as possible with the digit ﬁnger of
their preferred hand, and to withhold the response in
presence of a NoGo stimulus, of a Go not preceded
by a cue (40 trials), or of any other irrelevant letters.
The task was practised prior to task performance and
lasted 11 min. The task followed a 2 × 3 min resting-
state recording, and was run as ﬁrst in a battery of
three cognitive–EEG tasks.
Cognitive performance measures included target
mean reaction time (MRT, i.e. mean latency of
responding in ms after target onset), RTV (measured
as standard deviation of target reaction time) and
number of errors. MRT and RTV were calculated
across correctly answered Go trials. Errors included
omission errors (non-response to Go trials), total com-
mission errors (response to cue, NoGo or distractor
stimuli) and OXO-not-XOX commission errors
(response to a Go not following a cue).
Electrophysiological recording and analysis
The EEG was recorded from a 62-channel DC-coupled
recording system (extended 10–20 montage), using a
500 Hz sampling rate, impedances under 10 kΩ, and
FCz as the recording reference. The electro-oculograms
were recorded from electrodes above and below the
left eye and at the outer canthi. The EEG data were
analysed using Brain Vision Analyser 2.0 (Brain
Products). Researchers were blind to group status dur-
ing EEG pre-processing and analysis. Raw EEG record-
ings were down-sampled to 256 Hz, re-referenced to
the average of all electrodes, and digitally ﬁltered
using Butterworth band-pass ﬁlters (0.1–30 Hz, 24
dB/octave). All trials were also visually inspected for
electrical artefacts (due to electrical noise in the EEG
recording) or obvious movement, and sections of
data containing artefacts were removed manually.
Ocular artefacts, corresponding to blink-related and
vertical and horizontal eye movements, were identiﬁed
using the infomax Independent Component Analysis
algorithm (ICA; Jung et al. 2000), which allows for re-
moval of the components associated with ocular arte-
facts by back-projection of all but those components.
Sections of data with remaining artefacts exceeding
±100 µV in any channel or with a voltage step greater
than 50 µV were automatically rejected. Baseline cor-
rection was performed using a 500-ms pre-stimulus
reference period1†.
Stimulus-locked epochs (stimulus window from−200
to 1650 ms) were averaged based on three different
response conditions: cue, Go and NoGo. Averages
only included trials with correct responses (Go) or cor-
rectly rejected trials (NoGo and cue) and contained at
least 20 artefact-free segments (see online Supplemen-
tary material for number of segments included in the
ERP average by group). ERP measures were identiﬁed
within the selected electrodes and latency windows
for which effects were expected to be largest, based on
previous studies (McLoughlin et al. 2010, 2011;
Albrecht et al. 2013; Doehnert et al. 2013) and veriﬁed
against the topographic maps and the grand averages
(Figs 1–3). ERPs were measured as the mean amplitude
in the designated latency window. This approach has
been adopted in previous similar studies (Groom et al.
2010; Tye et al. 2014), and has the advantage of being
unaffected by latency variability (Luck, 2005). In cue
trials, the P3 was measured at Pz between 300 and
650 ms, and the CNV at Cz between 1300 and 1650
ms. In NoGo trials, the N2 was measured at Fz between
175 and 325 ms, and the P3 at Cz between 250 and 550
ms. In Go trials, the P3 was measured at CPz between
250 and 500 ms. A clear N2 was not observed in Go
trials, in line with other studies on tasks inducing a
low-conﬂict-monitoring demand (Bokura et al. 2001;
Gajewski & Falkenstein, 2013) and was not included
into the analysis.
Statistical analyses
All participants were included in the analysis of cogni-
tive performance data. Two ADHD participants were
excluded from the ERP analysis of the Go condition
due to having less than 20 artefact-free segments avail-
able for analysis.
Group differences on the reaction time measures
were explored using univariate analyses of variance
(ANOVAs), followed by post-hoc t tests. MRT and
RTV had skewed distributions and were log-
transformed with optimized minimal skew through
the ‘lnskew0’ command in Stata (Stata Corp.).
Performance accuracy was generally high as errors
were rare, in line with previous studies on this task
(McLoughlin et al. 2010, 2011; Albrecht et al. 2013;
Doehnert et al. 2013). Since distribution of errors was
thus not normal and no transformations were success-
ful, effects of group on these variables were entered
into non-parametric analysis, using Kruskal–Wallis
tests, followed by post-hoc Mann–Whitney U tests.
Group effects on ERP parameters were tested with
separate ANOVAs, followed by post-hoc t tests. All
ERP measures had normal distribution. We report
both p values (p < 0.05 for signiﬁcance and p < 0.10 for
a trend) and effect sizes (Cohen’s d) for comparisons
of cognitive performance and ERP measures. Effect
sizes were calculated using the difference in the
means, divided by the pooled standard deviation,† The notes appear after the main text.
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Fig. 1. (a) Grand average event-related potentials to cue stimuli at the Cz electrode, showing the contingent negative variation
in the 1300–1650 ms window. ADHD, Attention-deﬁcit/hyperactivity disorder (light grey; red online); BD, bipolar disorder
(mid grey; green online). Controls are shown in black. (b) Topographic maps for each group. For a colour ﬁgure, see the
online version.
Fig. 2. (a) Grand average event-related potentials to NoGo stimuli at the Fz electrode, showing the NoGo-N2 in the 175–325
ms window. ADHD, Attention-deﬁcit/hyperactivity disorder (light grey; red online); BD, bipolar disorder (mid grey; green
online). Controls are shown in black. (b) Topographic maps for each group. For a colour ﬁgure, see the online version.
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where d = 0.20 constitutes a small effect, d = 0.50 a me-
dium effect and d = 0.80 a large effect (Cohen, 1988).
Ethical standards
All procedures contributing to this work comply with
the ethical standards of the relevant national and insti-
tutional committees on human experimentation and
with the Helsinki Declaration of 1975, as revised in
2008.
Results
Cognitive performance measures
A trend-level effect of group emerged for RTV (F2,57 =
2.67, p = 0.08). Post-hoc analyses revealed a signiﬁcant
difference between the BD and control groups (p =
0.03) and a trend-level difference between the ADHD
and control groups (p = 0.06) on RTV, both with me-
dium effect sizes (Table 1), but no differences between
the ADHD and BD groups (p = 0.93). Groups did not
differ on MRT (F2,57 = 1.47, p = 0.24).
Trend-level effects emerged on the number of total
commission errors (H2 = 4.96, p = 0.08) and omission
errors (H2 = 4.74, p = 0.09). Post-hoc analyses indicated
that participants with ADHD made signiﬁcantly
more commission (p = 0.03) and omission (p = 0.04)
errors than controls, with medium and small effect
sizes, respectively (Table 1). Participants with BD
showed a trend-level difference on the number of
omission errors (p = 0.07) from controls, with a small
effect size, but no difference on commission errors
(p = 0.34). The ADHD and BD groups did not differ
on commission (p = 0.20) or omission (p = 0.90) errors.
No effect of group emerged for OXO-not-XOX com-
mission errors (H2 = 3.81, p = 0.15).
ERP parameters
Cue condition
An effect of group did not emerge on the Cue-P3
(F2,57 = 1.31, p = 0.28).
A trend-level effect of group emerged for the CNV
(F2,57 = 2.86, p = 0.07). Post-hoc comparisons showed a
signiﬁcant difference between the ADHD and control
groups (p = 0.05) and a trend-level difference between
the BD and control groups (p = 0.09), both with me-
dium effect size (Table 1). No difference emerged be-
tween the two clinical groups (p = 0.85).
NoGo condition
There was a signiﬁcant effect of group on the NoGo-N2
(F2,57 = 4.03, p = 0.02). Post-hoc analyses revealed that
the BD group signiﬁcantly differed from the ADHD
Fig. 3. (a) Grand average event-related potentials to NoGo stimuli at the Cz electrode, showing the NoGo-P3 in the 250–550
ms window. ADHD, Attention-deﬁcit/hyperactivity disorder (light grey; red online); BD, bipolar disorder (mid grey; green
online). Controls are shown in black. (b) Topographic maps for each group. For a colour ﬁgure, see the online version.
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(p = 0.015) and control (p = 0.04) groups, with large and
medium effect sizes, respectively (Table 1). The ADHD
and control groups did not differ from each other
(p = 0.66).
A signiﬁcant effect of group emerged on the
NoGo-P3 (F2,57 = 3.86, p = 0.03). Post-hoc analyses
showed that both the ADHD (p = 0.01) and BD (p =
0.03) groups signiﬁcantly differed from controls, re-
spectively, with large and medium effect sizes
(Table 1), but not from each other (p = 0.88).
Go condition
No signiﬁcant effect of group emerged on the Go-P3
(F2,55 = 0.73, p = 0.49).
Discussion
In a direct comparison of women with ADHD, women
with BD and control women on cognitive performance
and ERP measures from a CPT-OX task, we report evi-
dence for both disorder-speciﬁc (conﬂict monitoring)
and overlapping (inhibitory control and potentially re-
sponse preparation) neurophysiological impairments
across the disorders. The current study represents the
ﬁrst cognitive–electrophysiological investigation com-
paring attentional and inhibitory processing in adults
with ADHD and adults with BD. In addition, since
the majority of previous ERP studies on ADHD have
used male samples (McLoughlin et al. 2010, 2011;
Albrecht et al. 2013; Doehnert et al. 2013), and very
few studies of this kind have been conducted in BD,
our all-female sample furthers our understanding of
neurophysiological impairments in females with either
of these disorders.
Our ERP results show a signiﬁcant difference be-
tween the ADHD and BD groups in the amplitude of
the N2 in response to NoGo stimuli, which was
reduced in participants with BD compared with the
other two groups. The N2 is considered to reﬂect
conﬂict-monitoring processing (Holroyd et al. 2003;
Yeung & Cohen, 2006) and to depend on the amount
of correct response processing needed to overcome a
conﬂicting response. In the CPT-OX, this process may
be represented by the bias towards the response after
a cue, which requires the preparation of a response,
and produces increased conﬂict monitoring when the
prepared response has to be stopped in presence of a
non-target. The reduced N2 in women with BD aligns
with previous evidence of attenuated N2 elicited with
an oddball task (Ethridge et al. 2012) and of a reduced
ERN in error responses (Morsel et al. 2014). Both N2
and ERN in conditions inducing conﬂict, such as in
non-target or incongruent trials, are thought to reﬂect
Table 1. Cognitive performance and event-related potential measures from the cued continuous performance test: means, effect sizes and
signiﬁcance of group comparisons
ADHD (n = 20)a:
mean (S.D.)b
BD (n = 20):
mean (S.D.)b
Controls (n = 20):
mean (S.D.)b
ADHD v.
BD, effect
size: d
ADHD v.
controls, effect
size: d
BD v. controls,
effect size: d
MRT, ms 425.31 (75.74) 418.30 (67.41) 391.58 (63.68) 0.05 0.49d 0.44
RTV, ms 109.18 (58.83) 101.73 (37.77) 76.91 (39.24) 0.02 0.60d† 0.68d*
OE 1.10 (1.55) 1.35 (2.52) 0.60 (1.57) 0.12 0.32* 0.36†
OXO-not-XOX
CE
1.05 (1.88) 0.60 (2.04) 0.50 (0.89) 0.23 0.37 0.06
Total CE 7.25 (16.03) 2.40 (5.39) 0.75 (0.97) 0.41 0.57d* 0.43
Cue-P3 at Pz 2.30 (1.64) 1.36 (1.80) 1.83 (2.04) 0.56d 0.26 0.25
CNV at Cz −2.24 (1.03) −2.31 (1.36) −3.31 (2.12) 0.06 0.66d* 0.58d†
NoGo-N2 at Fz 0.57 (1.88) 2.41 (2.64) 0.84 (2.07) 0.83c* 0.14 0.68d*
NoGo-P3 at Cz 5.42 (2.73) 5.56 (3.31) 7.68 (2.57) 0.05 0.88c* 0.73d*
Go-P3 at CPz 5.01 (2.76) 5.56 (3.23) 6.10 (2.18) 0.19 0.45d 0.20
ADHD, Attention-deﬁcit/hyperactivity disorder; S.D., standard deviation; BD, bipolar disorder; MRT, mean reaction time;
RTV, within-subject variability in reaction times; OE, omission errors; CE, commission errors; CNV, contingent negative
variation.
a Only 18 participants with ADHD were included in the average of the Go condition, as two participants did not have at
least 20 artefact-free segments.
bMeans and S.D.S were calculated on raw data.
c Large effect size.
dMedium effect size.
* p < 0.05, † p < 0.10.
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conﬂict monitoring (Yeung & Cohen, 2006). Our results
may therefore indicate that women with BD show
impaired conﬂict monitoring compared with women
with ADHD and control women. In line with previous
studies using the CPT-OX (McLoughlin et al. 2010,
2011; Albrecht et al. 2013; Doehnert et al. 2013), we
did not ﬁnd an attenuated NoGo-N2 in women with
ADHD, although reduced N2 have been associated
with ADHD in tasks inducing higher conﬂict demands
(McLoughlin et al. 2009, 2014b).
We also identiﬁed abnormalities in ERPs that distin-
guished women in both clinical groups from controls,
indicating shared neurophysiological impairments
across ADHD and BD. The reduced P3 in response to
NoGo stimuli in both ADHD and BD groups, com-
pared with the control group, suggests a similar pat-
tern of impaired response inhibition to that
previously reported in investigations of children and
adults with ADHD (McLoughlin et al. 2010, 2011;
Albrecht et al. 2013; Doehnert et al. 2013). The reduced
NoGo-P3 in women with BD also aligns with previous
cognitive research ﬁnding deﬁcits in inhibitory control
in euthymic BD (Robinson et al. 2006, 2013). These
attenuations of the NoGo-P3 in both disorders there-
fore probably represent an area of overlapping impair-
ment in brain processes implicated in the inhibition of
incorrect response. Yet, this inhibitory control deﬁcit in
women with BD was temporally preceded by other
processing deﬁcits in the NoGo-N2. As such, in ERPs
to non-targets, while women with ADHD seem pri-
marily impaired in response inhibition, women with
BD show a broader deﬁcit in both conﬂict monitoring
and inhibitory control.
Additionally, we report an attenuation in the CNV
in women with ADHD compared with controls, and
also potentially in women with BD (trend-level differ-
ence), both with a medium effect size. These results
replicate previous studies reporting reduced CNV in
individuals with ADHD (McLoughlin et al. 2010,
2011; Albrecht et al. 2013; Doehnert et al. 2013; Tye
et al. 2014), and suggest another potential area of
shared impairment with BD. However, we note that
the comparison between BD and control participants
was only at trend level. If replicated also in BD, this at-
tenuation of the CNV would index an overlapping im-
pairment in response preparation in the two disorders.
The lack of a difference between women with
ADHD and controls in the Cue-P3 is inconsistent
with some previous investigations showing a reduced
Cue-P3 in ADHD samples (McLoughlin et al. 2010;
Albrecht et al. 2013). Yet, these attenuations have not
been reported in all studies (Dhar et al. 2010; Skirrow,
2012) and the difference in the Cue-P3 emerged as
signiﬁcant, but with a small effect size, in a recent
larger-scale study of adolescents and young adults
with ADHD (Cheung et al. 2015). In the present
study, the normal Cue-P3 in ADHD may be due to
an effect of gender, the current study being the ﬁrst
using an all-female sample. An age-effect is also plaus-
ible, since this study included adults of a slightly older
and broader age range compared with previous inves-
tigations (e.g. McLoughlin et al. 2010) and develop-
mental changes have been reported for the Cue-P3,
suggesting that ADHD–control differences may de-
cline with age (Doehnert et al. 2013). Further studies
on larger samples that include participants of both
genders and a broader age range are needed to clarify
potential gender and age effects on these processes in
ADHD.
While ERP measures of conﬂict monitoring differen-
tiated the ADHD and BD groups, cognitive perform-
ance data did not suggest differences between the
two clinical groups. Our cognitive performance results
potentially suggest poorer performance and higher
RTV in both ADHD and BD groups, compared with
controls, consistent with previous studies reporting
lower accuracy and higher RTV in ADHD and BD in-
dependently (Brotman et al. 2009; Kuntsi et al. 2010;
Torralva et al. 2011). This pattern of results, with differ-
ences between ADHD and BD groups observed in the
neurophysiological markers but not at the cognitive
performance level, may reﬂect greater speciﬁcity of
the neurophysiological markers in detecting differ-
ences between clinical groups.
The following limitations of this study should be
taken into account when interpreting these data.
First, although the groups were matched on gender,
age and IQ, there were differences in the prescribed
medications that participants with ADHD or BD
were taking. While we asked participants with
ADHD to stop taking stimulant medications 48 h
prior to the assessment, it was not possible, for ethical
reasons, to ask participants to stop mood-stabilizing,
anti-psychotic or antidepressant medications. Given
limited numbers in medication subgroups, we were
not able to directly test the effect of medication on
ERP measures, which represents a limitation of the cur-
rent study. The effects of medication are difﬁcult to
control for in cross-disorder comparison studies
where different treatments may be prescribed to differ-
ent groups of psychiatric patients. Although the under-
standing of the effects of medications on ERPs is still
limited, previous studies suggest that medications
may normalize ERP measures (Anderer et al. 2002;
Karaaslan et al. 2003; Galletly et al. 2005). As such, in
this study, a medication effect could potentially have
resulted in ERPs comparable with controls. Yet, both
clinical groups, although some participants were medi-
cated, showed reduced ERP measures compared with
controls. Therefore, although the effect of medication
8 G. Michelini et al.
represents a potential confounder of this study andmay
have attenuated some case–control differences, we re-
port impairments in both clinical groups which may
not have been produced by the effect of medication.
Future studies on samples including non-medicated
individuals or a higher number of individuals in each
medication subgroup are needed to clarify whether
our results may have been affected by medication
effects. A second limitation is that, by using an area
measure, we were not able to obtain latency data. This
approach, previously adopted in similar ERP studies
(Groom et al. 2010; Tye et al. 2014), was preferred for
having the advantage, over peakmeasures, of being un-
affectedby latencyvariability andof providing a reliable
measure of amplitude even when the identiﬁcation of
clear peaks is not possible for all subjects (Luck, 2005).
Although some previous studies found prolonged
latency of ERP components in BD (Chun et al. 2013;
Maekawa et al. 2013), our ERP grand averages did not
suggest latency differences, thus our areameasure prob-
ably captured most of the differences between the
groups on ERP measures. Finally, in order to increase
homogeneity of the sample, this investigation was con-
ducted on an all-female sample, with slightly higher
than expected IQ in the clinical groups. Replication in fu-
ture investigations with bigger samples of both genders
and including individuals with a wider range of IQs is
required in order to generalize these ﬁndings to more
typical clinical populations.
Conclusion
In conclusion, our results represent some of the ﬁrst
evidence of disorder-speciﬁc and shared impairments
in brain processes involved in attentional orienting,
conﬂict monitoring and inhibitory control in women
with ADHD and BD, with moderate to large effect
sizes. This investigation of neurophysiological pro-
cesses furthers our understanding of impairments
associated with ADHD and BD, and the identiﬁcation
of objective measures showing differences between
ADHD and BD may assist in differentiating between
the two disorders when their distinction is not clear
at clinical consultations. If replicated in larger-scale
studies, the neurophysiological biomarkers of distinct
patterns in brain activity may aid in the identiﬁcation
of the diagnostic boundaries of ADHD and BD in
adults. More broadly, given that ADHD and BD are
both highly heritable disorders, the identiﬁed neuro-
physiological indices may represent intermediate phe-
notypes between diagnosis and genetic factors
inﬂuencing a disorder, as suggested by genetic and
family studies on ERP indices of attentional and inhibi-
tory processing showing shared familial/genetic
inﬂuences with ADHD (McLoughlin et al. 2011;
Albrecht et al. 2013, 2014). Future studies can investi-
gate causal models of ADHD and BD, by exploring
to what extent overlapping and disorder-speciﬁc
impairments in brain function are accounted for by
speciﬁc or shared genetic inﬂuences on the two disor-
ders and, in turn, further our understanding on the
pathways to distinct and overlapping features in
ADHD and BD.
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Note
1 Since most previous ERP analyses on CPT-OX did not
apply a baseline subtraction (Banaschewski et al. 2004;
McLoughlin et al. 2010, 2011; Albrecht et al. 2013;
Doehnert et al. 2013), analyses were also repeated without
baseline correction. Results of data without baseline
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correction were comparable for the NoGo-N2, NoGo-P3
and Go-P3, but partly changed for the Cue-P3 and CNV
(see Supplementary material).
References
Albrecht B, Brandeis D, Uebel H, Valko L, Heinrich H,
Drechsler R, Heise A, Müller UC, Steinhausen HC,
Rothenberger A, Banaschewski T (2013). Familiality of
neural preparation and response control in childhood
attention deﬁcit-hyperactivity disorder. Psychological
Medicine 43, 1997–2011.
Albrecht B, Brandeis D, Uebel-von Sandersleben H, Valko
L, Heinrich H, Xu X, Drechsler R, Heise A, Kuntsi J,
Müller UC, Asherson P, Steinhausen HC, Rothenberger
A, Banaschewski T (2014). Genetics of preparation and
response control in ADHD: the role of DRD4 and DAT1.
Journal of Child Psychology and Psychiatry 55, 914–923.
Altman EG, Hedeker D, Peterson JL, Davis JM (1997). The
Altman Self-Rating Mania Scale. Biological Psychiatry 42,
948–955.
Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD
(2002). Perceptual and cognitive event-related potentials in
neuropsychopharmacology: methodological aspects and
clinical applications (pharmaco-ERP topography and
tomography). Methods and Findings in Experimental and
Clinical Pharmacology 24, 121–137.
APA (2000). Diagnostic and Statistical Manual ofMental Disorders.
American Psychiatric Association: Washington, DC.
Asherson P, Young AH, Eich-Höchli D, Moran P, Porsdal V,
Deberdt W (2014). Differential diagnosis, comorbidity, and
treatment of attention-deﬁcit/hyperactivity disorder in
relation to bipolar disorder or borderline personality
disorder in adults. Current Medical Research and Opinion 30,
1657–1672.
Banaschewski T, Brandeis D (2007). Annotation: what
electrical brain activity tells us about brain function that
other techniques cannot tell us – a child psychiatric
perspective. Journal of Child Psychology and Psychiatry 48,
415–435.
Banaschewski T, Brandeis D, Heinrich H, Albrecht B,
Brunner E, Rothenberger A (2004). Questioning inhibitory
control as the speciﬁc deﬁcit of ADHD – evidence from
brain electrical activity. Journal of Neural Transmission 111,
841–864.
Barry RJ, Clarke AR, McCarthy R, Selikowitz M, Brown CR,
Heaven PC (2009). Event-related potentials in adults with
attention-deﬁcit/hyperactivity disorder: an investigation
using an inter-modal auditory/visual oddball task.
International Journal of Psychophysiology 71, 124–131.
Beck AT, Steer RA, Ball R, Ranieri WF (1996). Comparison of
Beck Depression Inventories-IA and -II in psychiatric
outpatients. Journal of Personality Assessment 67, 588–597.
Bestelmeyer PE (2012). The visual P3a in schizophrenia and
bipolar disorder: effects of target and distractor stimuli on
the P300. Psychiatry Research 197, 140–144.
Bokura H, Yamaguchi S, Kobayashi S (2001).
Electrophysiological correlates for response inhibition in a
Go/NoGo task. Clinical Neurophysiology 112, 2224–2232.
Brotman MA, Rooney MH, Skup M, Pine DS, Leibenluft E
(2009). Increased intrasubject variability in response time in
youths with bipolar disorder and at-risk family members.
Journal of the American Academy of Child and Adolescent
Psychiatry 48, 628–635.
Cabranes JA, Ancín I, Santos JL, Sánchez-Morla E,
García-Jiménez MA, Rodríguez-Moya L, Fernández C,
Barabash A (2013). P50 sensory gating is a trait marker of
the bipolar spectrum. European Neuropsychopharmacology 23,
721–727.
Cheung CHM, Rijsdijk F, McLoughlin G, Brandeis D,
Banaschewski T, Asherson P, Kuntsi J (2015). Cognitive
and neurophysiological markers of ADHD persistence and
remission. British Journal of Psychiatry. Published online 6
August 2015. doi:10.1192/bjp.bp.114.145185.
Chun J, Karam ZN, Marzinzik F, Kamali M, O’Donnell L,
Tso IF, Manschreck TC, McInnis M, Deldin PJ (2013). Can
P300 distinguish among schizophrenia, schizoaffective and
bipolar I disorders? An ERP study of response inhibition.
Schizophrenia Research 151, 175–184.
Cohen J (1988). Statistical Power Analysis for the Behavioral
Sciences, 2nd edn.LawrenceErlbaumAssociates:Hillsdale,NJ.
Das D, Cherbuin N, Butterworth P, Anstey KJ, Easteal S
(2012). A population-based study of attention deﬁcit/
hyperactivity disorder symptoms and associated
impairment in middle-aged adults. PLOS One 7, e31500.
Dhar M, Been PH, Minderaa RB, Althaus M (2010).
Information processing differences and similarities in adults
with dyslexia and adults with attention deﬁcit hyperactivity
disorder during a continuous performance test: a study of
cortical potentials. Neuropsychologia 48, 3045–3056.
Doehnert M, Brandeis D, Imhof K, Drechsler R,
Steinhausen HC (2010). Mapping attention-deﬁcit/
hyperactivity disorder from childhood to adolescence – no
neurophysiologic evidence for a developmental lag of
attention but some for inhibition. Biological Psychiatry 67,
608–616.
Doehnert M, Brandeis D, Schneider G, Drechsler R,
Steinhausen HC (2013). A neurophysiological marker of
impaired preparation in an 11-year follow-up study of
attention-deﬁcit/hyperactivity disorder (ADHD). Journal of
Child Psychology and Psychiatry 54, 260–270.
Doehnert M, Brandeis D, Straub M, Steinhausen HC,
Drechsler R (2008). Slow cortical potential neurofeedback
in attention deﬁcit hyperactivity disorder: is there
neurophysiological evidence for speciﬁc effects? Journal of
Neural Transmission 115, 1445–1456.
Ethridge LE, Hamm JP, Shapiro JR, Summerfelt AT, Keedy
SK, Stevens MC, Pearlson G, Tamminga CA, Boutros NN,
Sweeney JA, Keshavan MS, Thaker G, Clementz BA
(2012). Neural activations during auditory oddball
processing discriminating schizophrenia and psychotic
bipolar disorder. Biological Psychiatry 72, 766–774.
Faraone SV, Biederman J (2005). What is the prevalence of
adult ADHD? Results of a population screen of 966 adults.
Journal of Attention Disorders 9, 384–391.
Gajewski PD, Falkenstein M (2013). Effects of task
complexity on ERP components in Go/Nogo tasks.
International Journal of Psychophysiology 87, 273–278.
10 G. Michelini et al.
Galletly CA, Clark CR, McFarlane AC (2005). Clozapine
improves working memory updating in schizophrenia.
European Neuropsychopharmacology 15, 601–608.
Groom MJ, Scerif G, Liddle PF, Batty MJ, Liddle EB,
Roberts KL, Cahill JD, Liotti M, Hollis C (2010). Effects of
motivation and medication on electrophysiological markers
of response inhibition in children with attention-deﬁcit/
hyperactivity disorder. Biological Psychiatry 67, 624–631.
Hall MH, Rijsdijk F, Kalidindi S, Schulze K, Kravariti E,
Kane F, Sham P, Bramon E, Murray RM (2007). Genetic
overlap between bipolar illness and event-related
potentials. Psychological Medicine 37, 667–678.
Henry BL, Minassian A, Perry W (2013). Everyday functional
ability across different phases of bipolar disorder. Psychiatry
Research 210, 850–856.
Holroyd CB, Nieuwenhuis S, Yeung N, Cohen JD (2003).
Errors in reward prediction are reﬂected in the
event-related brain potential. Neuroreport 14, 2481–2484.
Hosang GM, Uher R, Maughan B, McGufﬁn P, Farmer AE
(2012). The role of loss and danger events in symptom
exacerbation in bipolar disorder. Journal of Psychiatric
Research 46, 1584–1589.
Ibanez A, Cetkovich M, Petroni A, Urquina H, Baez S,
Gonzalez-Gadea ML, Kamienkowski JE, Torralva T,
Torrente F, Strejilevich S, Teitelbaum J, Hurtado E, Guex
R, Melloni M, Lischinsky A, Sigman M, Manes F (2012).
The neural basis of decision-making and reward processing
in adults with euthymic bipolar disorder or
attention-deﬁcit/hyperactivity disorder (ADHD). PLOS
ONE 7, e37306.
Jahshan C, Wynn JK, Mathis KI, Altshuler LL, Glahn DC,
Green MF (2012). Cross-diagnostic comparison of duration
mismatch negativity and P3a in bipolar disorder and
schizophrenia. Bipolar Disorders 14, 239–248.
Jung TP, Makeig S, Humphries C, Lee TW, McKeown MJ,
Iragui V, Sejnowski TJ (2000). Removing
electroencephalographic artifacts by blind source
separation. Psychophysiology 37, 163–178.
Karaaslan F, Gonul AS, Oguz A, Erdinc E, Esel E (2003).
P300 changes in major depressive disorders with and
without psychotic features. Journal of Affective Disorders 73,
283–287.
Kooij JJS, Francken MH (2007). Diagnostic Interview for
ADHD in Adults (DIVA) (http://www.psyq.nl/ﬁles/
1263005/DIVA_2_EN.pdf). Accessed September 2015.
Kuntsi J, Klein C (2012). Intraindividual variability in ADHD
and its implications for research of causal links. Current
Topics in Behavioral Neurosciences 9, 67–91.
Kuntsi J, Wood AC, Rijsdijk F, Johnson KA, Andreou P,
Albrecht B, Arias-Vasquez A, Buitelaar JK, McLoughlin
G, Rommelse NN, Sergeant JA, Sonuga-Barke EJ, Uebel
H, van der Meere JJ, Banaschewski T, Gill M, Manor I,
Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger
A, Steinhausen HC, Faraone SV, Asherson P (2010).
Separation of cognitive impairments in attention-deﬁcit/
hyperactivity disorder into 2 familial factors. Archives of
General Psychiatry 67, 1159–1167.
Luck SJ (2005). An Introduction to the Event-Related Potential
Technique. MIT Press: Cambridge, MA.
Maekawa T, Katsuki S, Kishimoto J, Onitsuka T, Ogata K,
Yamasaki T, Ueno T, Tobimatsu S, Kanba S (2013).
Altered visual information processing systems in bipolar
disorder: evidence from visual MMN and P3. Frontiers in
Human Neuroscience 7, 403.
McLoughlin G, Albrecht B, Banaschewski T, Rothenberger
A, Brandeis D, Asherson P, Kuntsi J (2009). Performance
monitoring is altered in adult ADHD: a familial
event-related potential investigation. Neuropsychologia 47,
3134–3142.
McLoughlin G, Albrecht B, Banaschewski T, Rothenberger
A, Brandeis D, Asherson P, Kuntsi J (2010).
Electrophysiological evidence for abnormal preparatory
states and inhibitory processing in adult ADHD. Behavioral
and Brain Functions 6, 66.
McLoughlin G, Asherson P, Albrecht B, Banaschewski T,
Rothenberger A, Brandeis D, Kuntsi J (2011). Cognitive–
electrophysiological indices of attentional and inhibitory
processing in adults with ADHD: familial effects. Behavioral
and Brain Functions 7, 26.
McLoughlin G, Makeig S, Tsuang MT (2014a). In search of
biomarkers in psychiatry: EEG-based measures of brain
function. American Journal of Medical Genetics Part B:
Neuropsychiatric Genetics 165B, 111–121.
McLoughlin G, Palmer JA, Rijsdijk F, Makeig S (2014b).
Genetic overlap between evoked frontocentral theta-band
phase variability, reaction time variability, and
attention-deﬁcit/hyperactivity disorder symptoms in a twin
study. Biological Psychiatry 75, 238–247.
Merikangas KR, He JP, Burstein M, Swendsen J, Avenevoli
S, Case B, Georgiades K, Heaton L, Swanson S, Olfson M
(2011). Service utilization for lifetime mental disorders in US
adolescents: results of the National Comorbidity Survey–
Adolescent Supplement (NCS-A). Journal of the American
Academy of Child and Adolescent Psychiatry 50, 32–45.
Morsel AM, Morrens M, Temmerman A, Sabbe B, de Bruijn
ER (2014). Electrophysiological (EEG) evidence for reduced
performance monitoring in euthymic bipolar disorder.
Bipolar Disorders 16, 820–829.
Pini S, de Queiroz V, Pagnin D, Pezawas L, Angst J, Cassano
GB, Wittchen HU (2005). Prevalence and burden of bipolar
disorders in European countries. European
Neuropsychopharmacology 15, 425–434.
Robinson LJ, Thompson JM, Gallagher P, Goswami U,
Young AH, Ferrier IN, Moore PB (2006). A meta-analysis
of cognitive deﬁcits in euthymic patients with bipolar
disorder. Journal of Affective Disorders 93, 105–115.
Robinson LJ, Thompson JM, Gallagher P, Gray JM, Young
AH, Ferrier IN (2013). Performance monitoring and
executive control of attention in euthymic bipolar disorder:
employing the CPT-AX paradigm. Psychiatry Research 210,
457–464.
Schulze KK, Hall MH, McDonald C, Marshall N, Walshe M,
Murray RM, Bramon E (2008). Auditory P300 in patients
with bipolar disorder and their unaffected relatives. Bipolar
Disorders 10, 377–386.
Skirrow C (2012). Investigating Emotional Lability in Adults with
Attention Deﬁcit Hyperactivity Disorder: An Integrative
Approach. Ph.D. Thesis, King’s College London.
Neurophysiological impairments of attention and inhibition in attention-deﬁcit/hyperactivity disorder and bipolar disorder
11
Skirrow C, Ebner-Priemer U, Reinhard I, Malliaris Y, Kuntsi
J, Asherson P (2014). Everyday emotional experience of
adults with attention deﬁcit hyperactivity disorder:
evidence for reactive and endogenous emotional lability.
Psychological Medicine 44, 3571–3583.
Skirrow C, Hosang GM, Farmer AE, Asherson P (2012). An
update on the debated association between ADHD and
bipolar disorder across the lifespan. Journal of Affective
Disorders 141, 143–159.
Swann AC, Lijfﬁjt M, Lane SD, Steinberg JL, Acas MD, Cox
B, Moeller FG (2013). Pre-attentive information processing
and impulsivity in bipolar disorder. Journal of Psychiatric
Research 47, 1917–1924.
Torralva T, Gleichgerrcht E, Torrente F, Roca M, Strejilevich
SA, Cetkovich M, Lischinsky A, Manes F (2011).
Neuropsychological functioning in adult bipolar disorder
and ADHD patients: a comparative study. Psychiatry
Research 186, 261–266.
Torres IJ, Boudreau VG, Yatham LN (2007).
Neuropsychological functioning in euthymic bipolar
disorder: a meta‐analysis. Acta Psychiatrica Scandinavica 116,
17–26.
Tye C, Asherson P, Ashwood KL, Azadi B, Bolton P,
McLoughlin G (2014). Attention and inhibition in children
with ASD, ADHD and co-morbid ASD +ADHD: an
event-related potential study. Psychological Medicine 44,
1101–1116.
Valko L, Doehnert M, Müller UC, Schneider G, Albrecht B,
Drechsler R, Maechler M, Steinhausen HC, Brandeis D
(2009). Differences in neurophysiological markers of
inhibitory and temporal processing deﬁcits in children and
adults with ADHD. Journal of Psychophysiology 23, 235–246.
van Leeuwen TH, Steinhausen HC, Overtoom CC,
Pascual-Marqui RD, van’t Klooster B, Rothenberger A,
Sergeant JA, Brandeis D (1998). The continuous
performance test revisited with neuroelectric mapping:
impaired orienting in children with attention deﬁcits.
Behavioral and Brain Functions 94, 97–110.
Wechsler D (1999). Wechsler Abbreviated Scale of Intelligence
(WASI). Harcourt Assessment: San Antonio, TX.
Willcutt EG (2012). The prevalence of DSM-IV
attention-deﬁcit/hyperactivity disorder: a meta-analytic
review. Neurotherapeutics 9, 490–499.
Yeung N, Cohen JD (2006). The impact of cognitive deﬁcits
on conﬂict monitoring. Predictable dissociations between
the error-related negativity and N2. Psychological Science 17,
164–171.
Young RC, Biggs JT, Ziegler VE, Meyer DA (1978).
Rating-scale for mania – reliability, validity and sensitivity.
British Journal of Psychiatry 133, 429–435.
12 G. Michelini et al.
